izpis_h1_title_alt

Extracellular cystatin F is internalised by cytotoxic T lymphocytes and decreases their cytotoxicity
ID Prunk, Mateja (Author), ID Perišić, Milica (Author), ID Jakoš, Tanja (Author), ID Sabotič, Jerica (Author), ID Švajger, Urban (Author), ID Kos, Janko (Author)

.pdfPDF - Presentation file, Download (3,56 MB)
MD5: B5FCEA90FFA7037B47AD076461BC3B0C
URLURL - Source URL, Visit https://www.mdpi.com/2072-6694/12/12/3660 This link opens in a new window

Abstract
Cystatin F is a protein inhibitor of cysteine cathepsins, peptidases involved in the activation of the effector molecules of the perforin/granzyme pathway. Cystatin F was previously shown to regulate natural killer cell cytotoxicity. Here, we show that extracellular cystatin F has a role in regulating the killing efficiency of cytotoxic T lymphocytes (CTLs). Extracellular cystatin F was internalised into TALL-104 cells, a cytotoxic T cell line, and decreased their cathepsin C and H activity. Correspondingly, granzyme A and B activity was also decreased and, most importantly, the killing efficiency of TALL-104 cells as well as primary human CTLs was reduced. The N-terminally truncated form of cystatin F, which can directly inhibit cathepsin C (unlike the full-length form), was more effective than the full-length inhibitor. Furthermore, cystatin F decreased cathepsin L activity, which, however, did not affect perforin processing. Cystatin F derived from K-562 target cells could also decrease the cytotoxicity of TALL-104 cells. These results clearly show that, by inhibiting cysteine cathepsin proteolytic activity, extracellular cystatin F can decrease the cytotoxicity of CTLs and thus compromise their function.

Language:English
Keywords:cystatin F, cathepsins, cytotoxic lymphocytes, granzymes, perforin, TALL-104
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2020
Number of pages:14 str.
Numbering:Vol. 12, iss. 12, art. 3660
PID:20.500.12556/RUL-134854 This link opens in a new window
UDC:616.1
ISSN on article:2072-6694
DOI:10.3390/cancers12123660 This link opens in a new window
COBISS.SI-ID:43955203 This link opens in a new window
Publication date in RUL:04.02.2022
Views:1003
Downloads:132
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Cancers
Shortened title:Cancers
Publisher:MDPI
ISSN:2072-6694
COBISS.SI-ID:517914137 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:06.12.2020

Secondary language

Language:Slovenian
Keywords:cistatin F, katepsini, citotoksični limfociti

Projects

Funder:ARRS - Slovenian Research Agency
Project number:J4-1776
Name:Izboljšanje imunoterapevtske vrednosti NK celic z modulacijo cistatina F

Funder:ARRS - Slovenian Research Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back